These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 16551972)

  • 1. Bleeding in carriers of hemophilia.
    Plug I; Mauser-Bunschoten EP; Bröcker-Vriends AH; van Amstel HK; van der Bom JG; van Diemen-Homan JE; Willemse J; Rosendaal FR
    Blood; 2006 Jul; 108(1):52-6. PubMed ID: 16551972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bleeding symptoms in carriers of hemophilia A and B.
    Mauser Bunschoten EP; van Houwelingen JC; Sjamsoedin Visser EJ; van Dijken PJ; Kok AJ; Sixma JJ
    Thromb Haemost; 1988 Jun; 59(3):349-52. PubMed ID: 2847347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. X Chromosome inactivation: a modifier of factor VIII and IX plasma levels and bleeding phenotype in Haemophilia carriers.
    Garagiola I; Mortarino M; Siboni SM; Boscarino M; Mancuso ME; Biganzoli M; Santagostino E; Peyvandi F
    Eur J Hum Genet; 2021 Feb; 29(2):241-249. PubMed ID: 33082527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Haemophilia].
    Loomans JI; Lock J; Peters M; Leebeek FW; Cnossen MH; Fijnvandraat K
    Ned Tijdschr Geneeskd; 2014; 158():A7357. PubMed ID: 25351381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bleeding risk assessment in hemophilia A carriers from Dakar, Senegal.
    Seck M; Faye BF; Sall A; Sy D; Touré SA; Dieng N; Guéye YB; Gadji M; Touré AO; Costa C; Lasne D; Rothschild C; Diop S
    Blood Coagul Fibrinolysis; 2017 Dec; 28(8):642-645. PubMed ID: 28731872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clotting factor level is not a good predictor of bleeding in carriers of haemophilia A and B.
    Olsson A; Hellgren M; Berntorp E; Ljung R; Baghaei F
    Blood Coagul Fibrinolysis; 2014 Jul; 25(5):471-5. PubMed ID: 24509327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of correlation between X chromosome inactivation pattern and plasma concentration of factor VIII and factor IX in carriers of haemophilia A and B.
    Orstavik KH; Scheibel E; Ingerslev J; Schwartz M
    Thromb Haemost; 2000 Mar; 83(3):433-7. PubMed ID: 10744150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Population and molecular-genetic aspects of hemophilia A and B in Uzbekistan].
    Boboev KT
    Tsitol Genet; 2008; 42(2):51-4. PubMed ID: 18630121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Both hemophilia health care providers and hemophilia a carriers report that carriers have excessive bleeding.
    Paroskie A; Oso O; Almassi B; DeBaun MR; Sidonio RF
    J Pediatr Hematol Oncol; 2014 May; 36(4):e224-30. PubMed ID: 24309601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemophilia A/B carriers: haemorrhagic burden of disease and open issues.
    Pasca S; Zanon E
    Blood Transfus; 2020 Nov; 18(6):496-497. PubMed ID: 32955424
    [No Abstract]   [Full Text] [Related]  

  • 11. Hemophilia in Iran.
    Dorgalaleh A; Dadashizadeh G; Bamedi T
    Hematology; 2016 Jun; 21(5):300-10. PubMed ID: 26914731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trypsin clotting time (K-test) in hemophilia A and in hemophilia B1.
    Girolami A; Dal Bo Zanon R; Procidano M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(6):863-71. PubMed ID: 6176512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe hemophilia with mild bleeding phenotype: molecular characterization and global coagulation profile.
    Santagostino E; Mancuso ME; Tripodi A; Chantarangkul V; Clerici M; Garagiola I; Mannucci PM
    J Thromb Haemost; 2010 Apr; 8(4):737-43. PubMed ID: 20102490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of the prevalence of clotting factor deficiency in carriers of haemophilia A and haemophilia B.
    Boban A; Lambert C; Lannoy N; Hermans C
    Haemophilia; 2017 Sep; 23(5):e471-e473. PubMed ID: 28689376
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical pattern of hemophilia and causes of variability.
    Mingot-Castellano ME
    Blood Coagul Fibrinolysis; 2019 Sep; 30(1S Suppl 1):S4-S6. PubMed ID: 31517708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor VIII and IX variants. Relationship between haemophilia B M and haemophilia B+.
    Meyer D; Larrieu MJ; Obert B
    Eur J Clin Invest; 1971 Sep; 1(6):425-31. PubMed ID: 5121733
    [No Abstract]   [Full Text] [Related]  

  • 17. Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B.
    Stobart K; Iorio A; Wu JK
    Cochrane Database Syst Rev; 2006 Apr; (2):CD003429. PubMed ID: 16625581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The measurement of low levels of factor VIII or factor IX in hemophilia A and hemophilia B plasma by clot waveform analysis and thrombin generation assay.
    Matsumoto T; Shima M; Takeyama M; Yoshida K; Tanaka I; Sakurai Y; Giles AR; Yoshioka A
    J Thromb Haemost; 2006 Feb; 4(2):377-84. PubMed ID: 16420569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemophilia with factor VIII and factor IX inhibitors, incidence, bleeding problems and management.
    Mahasandana C; Patharathienskul D; Suvatte V
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():106-12. PubMed ID: 7886549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The evolution of recombinant factor replacement for hemophilia.
    Sankar AD; Weyand AC; Pipe SW
    Transfus Apher Sci; 2019 Oct; 58(5):596-600. PubMed ID: 31421983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.